Study shows antibody growth from AstraZeneca, Sputnik Light COVID-19 vaccine mix

A small-scale clinical study of the combined use of the AstraZeneca and Sputnik Light vaccines against COVID-19 has shown strong antibody growth in a majority of the study’s participants, the Russian Direct Investment Fund said on Monday.

The data was collected from 20 people who took part in a 100-person study in Azerbaijan that began in February. They first received the AstraZeneca shot followed by the one-dose Russian-made Sputnik Light shot 29 days later, RDIF said.

“According to the results of the interim analysis, a fourfold or higher increase in neutralising antibodies to the spike protein (S-protein) of the SARS-CoV-2 was found in 85% of the volunteers on the 57th day of the study,” RDIF said.

Similar Articles

Most Popular

Australia says EU postpones trade talks for second time

Economy3 minutes ago (Oct 22, 2021 07:51AM ET) By Colin Packham CANBERRA (Reuters) - Australia's trade minister said on Friday the European Union has postponed...

Take Five: ECB, FAANG and China’s bond conundrum

(C) Reuters. Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., October 21, 2021. REUTERS/Brendan McDermid (Reuters)...

Ethiopian government strikes Tigray regional capital for fourth day this week

World14 minutes ago (Oct 22, 2021 06:41AM ET) ADDIS ABABA (Reuters) -Ethiopia conducted an air strike on the capital of the northern Tigray region on...

Subscribe here